Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.345 USD | -7.24% |
|
-0.74% | -29.10% |
Jun. 05 | Sector Update: Health Care Stocks Rise Wednesday Afternoon | MT |
Jun. 05 | Adicet Bio Says US FDA Grants Fast Track Designation for ADI-001 to Treat Lupus Nephritis | MT |
Financials (USD)
Sales 2024 * | 1.67M | Sales 2025 * | 2.78M | Capitalization | 119M |
---|---|---|---|---|---|
Net income 2024 * | -119M | Net income 2025 * | -125M | EV / Sales 2024 * | 71.5 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 42.9 x |
P/E ratio 2024 * |
-0.89
x | P/E ratio 2025 * |
-0.92
x | Employees | 143 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.4% |
Latest transcript on Adicet Bio, Inc.
1 day | +3.57% | ||
1 week | +3.57% | ||
1 month | +0.69% | ||
3 months | -35.56% | ||
6 months | -4.61% | ||
Current year | -23.28% |
![Extreme 1.245](/images/extremecours_fleche.png)
![Extreme 1.245](/images/extremecours_fleche.png)
![Extreme 1.245](/images/extremecours_fleche.png)
![Extreme 1.1](/images/extremecours_fleche.png)
![Extreme 1.1](/images/extremecours_fleche.png)
![Extreme 1.1](/images/extremecours_fleche.png)
![Extreme 1.1](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Aya Jakobovits
FOU | Founder | 71 | 14-10-31 |
Chen Schor
CEO | Chief Executive Officer | 51 | 16-06-30 |
Brian Harvey
DFI | Director of Finance/CFO | 63 | 20-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steve Dubin
BRD | Director/Board Member | 70 | 20-09-14 |
Carl Gordon
CHM | Chairman | 59 | 15-08-14 |
Michael Kauffman
BRD | Director/Board Member | 60 | 21-11-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +10.39% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 1.345 | -7.24% | 425 361 |
24-06-13 | 1.45 | +3.57% | 578,127 |
24-06-12 | 1.4 | +8.53% | 721,083 |
24-06-11 | 1.29 | -1.53% | 920,179 |
24-06-10 | 1.31 | -2.96% | 558,322 |
Delayed Quote Nasdaq, June 13, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.28% | 119M | |
+46.03% | 55.66B | |
-7.53% | 38.98B | |
+36.02% | 38.8B | |
-9.38% | 27.32B | |
+12.31% | 26.29B | |
-16.38% | 20.25B | |
+30.79% | 12.76B | |
+28.57% | 12.18B | |
-0.36% | 12.12B |
- Stock Market
- Equities
- ACET Stock